MARCOS
FERNANDEZ FONDEVILA
Researcher in the period 2022-2024
MARIA JESUS
GONZALEZ RELLAN
Hired researcher Marie Curie
Publications by the researcher in collaboration with MARIA JESUS GONZALEZ RELLAN (13)
2024
-
Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice
Molecular Metabolism, Vol. 85
-
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway
Cell Reports Medicine, Vol. 5, Núm. 2
2023
-
Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8
-
Hepatic p63 regulates glucose metabolism by repressing SIRT1
Gut, Vol. 72, Núm. 3, pp. 472-483
-
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
Molecular Metabolism, Vol. 75
-
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
Cell Metabolism, Vol. 35, Núm. 9, pp. 1630-1645.e5
2022
-
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24
-
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis
Journal of Hepatology, Vol. 77, Núm. 1, pp. 15-28
-
O-GlcNAcylation: A Sweet Hub in the Regulation of Glucose Metabolism in Health and Disease
Frontiers in Endocrinology, Vol. 13
2021
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
-
Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points
Journal of Hepatology
-
The L-α-Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis
Hepatology, Vol. 73, Núm. 2, pp. 606-624
2018
-
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
Molecular Metabolism, Vol. 8, pp. 132-143